Citadel Advisors’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Citadel Advisors's VCYT Position: Q2 2026 in Review
Citadel Advisors sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 152,941 shares — an estimated $6.41M sold.
Citadel Advisors first reported a position in VCYT in Q4 2015 and held it in 34 quarters. The position peaked at $25.5M in Q1 2023. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Citadel Advisors reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
- Citadel Advisors sold 152,941 Veracyte shares in Q2 2026, an estimated $6.41M.
- Citadel Advisors first reported a position in Veracyte in Q4 2015 and held it in 34 quarters.
- Citadel Advisors's Veracyte position peaked at $25.5M in Q1 2023.
- 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.